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Abstract
Background: The trichothecene mycotoxins deoxynivalenol (DON) and trichothecin (TTC) are inhibitors of
eukaryotic protein synthesis. Their effect on cellular homeostasis is poorly understood. We report a systematic
functional investigation of the effect of DON and TTC on the yeast Saccharomyces cerevisiae using genetic array,
network and microarray analysis. To focus the genetic analysis on intracellular consequences of toxin action we
eliminated the PDR5 gene coding for a potent pleiotropic drug efflux protein potentially confounding results. We
therefore used a knockout library with a pdr5Δ strain background.
Results: DON or TTC treatment creates a fitness bottleneck connected to ribosome efficiency. Genes isolated by
systematic genetic array analysis as contributing to toxin resistance function in ribosome quality control, translation
fidelity, and in transcription. Mutants in the E3 ligase Hel2, involved in ribosome quality control, and several members
of the Rpd3 histone deacetylase complex were highly sensitive to DON. DON and TTC have similar genetic profiles
despite their different toxic potency. Network analysis shows a coherent and tight network of genetic interactions
among the DON and TTC resistance conferring gene products. The networks exhibited topological properties
commonly associated with efficient processing of information. Many sensitive mutants have a "slow growth" gene
expression signature. DON-exposed yeast cells increase transcripts of ribosomal protein and histone genes indicating
an internal signal for growth enhancement.
Conclusions: The combination of gene expression profiling and analysis of mutants reveals cellular pathways which
become bottlenecks under DON and TTC stress. These are generally directly or indirectly connected to ribosome
biosynthesis such as the general secretory pathway, cytoskeleton, cell cycle delay, ribosome synthesis and translation
quality control. Gene expression profiling points to an increased demand of ribosomal components and does not
reveal activation of stress pathways. Our analysis highlights ribosome quality control and a contribution of a histone
deacetylase complex as main sources of resistance against DON and TTC.
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Background
Trichothecene mycotoxins are toxic sesquiterpenoid sec-
ondary metabolites produced by mostly plant pathogenic
fungi of the genera Trichothecium, Myrothecium, Tricho-
derma, and Fusarium [1]. Deoxynivalenol (DON), accu-
mulates in infected small grain cereals and is a virulence
factor of F. graminearum in the course of Fusarium head
blight (FHB) disease, potentially causing health problems
to humans and animals [2]. Trichothecin (TTC) is pro-
duced by the grape dry rot pathogen Trichothecium
roseum and can be found in red wine [3]. TTC may have
mainly antagonistic activity against competing fungi and
is more toxic to yeast, presumably due to higher mem-
brane permeability caused by a hydrophobic side chain
(isocrotonyl-ester). The primary mode of action of both
DON and TTC is inhibition of eukaryotic protein syn-
thesis [4, 5]. Depending on the organism, cell type, ex-
posure and trichothecene derivative exposure can cause
a variety of phenotypes. In wheat, DON is a virulence
factor for F. graminearum required for fungal spread [6]
and is produced in the early stages during the host-
pathogen interaction [7]. In animals, trichothecenes
cause pleiotropic systemic effects ranging from feed re-
fusal to immune suppression [8]. In mammalian cells,
DON induces activation of double-stranded RNA-
associated protein kinase (PKR), recruits and induces
Map kinases (p38, JNK) which in turn activate their
downstream targets, and promotes degradation of 28S
rRNA [9]. Prolonged DON exposure triggers apoptosis
and rRNA cleavage [2]. In plants, trichothecenes modu-
late abiotic stress signalling and lead to the induction of
oxidative stress and cell death [10].
The plant-fungal interaction is complicated with
trichothecenes apparently playing several roles in a bio-
logical arms race. Genetic analysis of Fusarium-host
interaction and trichothecene effects is up to now most
thoroughly developed for wheat, barley and maize. In
wheat over 100 quantitative trait loci (QTLs) have been
described to contribute to resistance [11]. Qfhs.ndsu-
3BS, is strongly contributing to Fusarium spreading and
toxin resistance [12–14] and contains the (yet unidenti-
fied) Fhb1 resistance gene(s). It is likely that inhibition
of protein synthesis by DON is not the only factor inter-
fering with plant cellular physiology. DON is required
for efficient infection of wheat. F. graminearum tri5 mu-
tants which are unable to produce DON are prevented
from spreading to the next spikelet, however are infec-
tious. Metabolomic studies suggested that trichothecenes
and especially DON are not only inhibiting protein
biosynthesis but also directly repress plant resistance
mechanisms [15, 16]. Another layer of complexity of the
fungus-toxin-host system is introduced by the multiple
ways of toxin biotransformation. In wheat, glucosylation
and glutathione conjugation are major routes of DON
biotransformation [17, 18]. The overall role of toxin pro-
duction for the fungal life cycle is not clear. Plant patho-
genic fungi like Fusarium are saprophytes during large
parts of the year and trichothecenes might protect in-
fected grains against feeders, thus perhaps improving
survival of F. graminearum spores and grains. Tricho-
thecene metabolites may also provide protection against
fungivores such as mites and insects [19]. Furthermore,
they could play a role in the competition with other mi-
crobes co-occurring in soil and plant debris or provide
protection against mycoparasitic fungi. Nevertheless, the
effect of trichothecenes on cells and animals usually not
involved in the plant versus fungal warfare is of
economic significance. In experimental animal models,
acute DON poisoning causes emesis, whereas chronic
low-dose exposure elicits anorexia, growth retardation,
immunotoxicity as well as impaired reproduction and
development resulting from maternal intoxication. Path-
ophysiologic effects associated with DON include altered
neuroendocrine signalling, proinflammatory gene induc-
tion, disruption of the growth hormone axis, and altered
gut integrity [10].
Despite investigative efforts, the systemic effect of
trichothecene toxicity is not well-understood and there
is a gap in our knowledge about general mechanisms
that can protect cells against trichothecene toxins. Here
we investigate the impact of DON and TTC on the sim-
ple eukaryotic model organism Saccharomyces cerevisiae.
Yeast genetics pointed early to the molecular targets of
trichothecene toxicity and showed inhibition of eukaryotic
translation by targeting the yeast ribosomal protein L3
[20, 21]. The yeast deletion collection is a perfect tool to
study effects of drugs in a systematic genetics analysis
[22–25] and has even been used for a yeast genetics ex-
periment in space [26]. Two genetic survey studies have
been reported identifying yeast mutants resistant and
hypersensitive to TTC [27, 28]. These studies both sug-
gested that TTC sensitivity is connected to mitochondrial
dysfunction and the resulting intracellular oxidative stress.
To gain insights into the DON defence response of a sim-
ple eukaryotic cell we screened the yeast deletion collec-
tion for sensitive strains and performed gene expression
profiling. The DON sensitivity of yeast was increased
in our screen by elimination of the drug efflux ABC
transporter Pdr5. Interestingly, PDR5 has not been
listed as gene involved in TTC resistance in a previ-
ous study [28]. Pdr5 contributes highly to yeast DON
and TTC resistance and is controlled by the status of
the mitochondria [29]. Thus elimination of this path-
way should reveal intracellular hotspots for general
trichothecene resistance. Yeast genes isolated here in
a background lacking Pdr5 point to cytoplasmic effi-
ciency and rRNA synthesis as rate limiting for fitness
in the presence of DON and TTC.
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Results and discussion
To define the impact of DON on cellular processes we
screened the yeast deletion library for mutants exhibiting
sensitivity to DON and TTC. A previous study analysed
yeast deletion mutants treated with TTC [28]. Such a
screen has not been reported for DON due to its low
toxicity in yeast. To focus on specific intracellular mech-
anisms conferring resistance we tried to reduce drug
efflux. Our initial observations suggested a major role of
the ABC-type drug efflux pump Pdr5 and that this pro-
tein is necessary and sufficient to confer resistance to
the trichothecenes DON and TTC. In yeast, PDR5 and
numerous ABC transporters and pleiotropic drug resist-
ance genes are regulated by the transcription factors
Pdr1 and Pdr3 [30]. Deletion of both genes (pdr1 pdr3)
leads to higher TTC and DON sensitivity and deletion
of PDR5 causes an even stronger toxin sensitivity pheno-
type (Fig. 1a). Trichothecene resistance can be restored
in a pdr1 pdr3 double mutant by constitutive high
ADH1 promoter driven expression of PDR5 alone
(Fig. 1a). A gain of function allele of Pdr1 (PDR1-3) leads
to overexpression of PDR5 and other drug resistance
genes [31] and causes increased resistance to high con-
centrations of TTC. Deleting PDR5 in the dominant
PDR1-3 background leads to toxin sensitivity, indicating
that other genes upregulated by PDR1-3 do not play a
major role (Fig. 1b). As expected, a deletion of PDR5 did
also confer higher sensitivity against DON in the strain
background of the knock out collection (Fig. 1c). Elimin-
ation of the PDR5 gene from the collection was an im-
portant step to lower the required DON concentration.
A further advantage of the absence of PDR5 from the
knockout collection is that we avoid those mutants
which are DON/TTC sensitive due to changed PDR5 ex-
pression. Expression of PDR5 is not constitutive [32]
and subject to retrograde signaling [29]. A conserved
mechanism is increasing the expression of the transcrip-
tion factor Pdr3 in yeast leading to enhanced Pdr5
expression. Similarly, in the related yeast Candida glab-
rata CgPdr1 induces the Pdr5 homolog Cdr1 [33].
Importantly, DON exposure increases PDR1 and PDR3
expression [34]. Thus, one difference of our study to
previous ones is the insensitivity of our PDR5 deleted
mutant collection to variations of Pdr5 levels.
The library of double mutants was generated using the
SGA protocol [35]. The query strain carrying the PDR5
gene knockout was mated with the strains of the yeast
deletion collection. The diploid strains were selected and
then sporulated. The desired haploid double mutant seg-
regants were obtained by counter selection against the
diploid and other meiotic products [35]. The initial
screen for sensitive double mutants of this library was
performed with 70 mg/l DON and 0.3 mg/l TTC on
solid rich medium and followed by a subsequent rescre-
ening. We identified a total of 248 strains of which 92




Fig. 1 Pdr5 confers TTC and DON resistance. Logarithmic phase cultures in YPD medium were diluted to OD600 0.1. Then 5 μl of this and three serial
1:6 dilutions were spotted on YPD plates containing the indicated amount of toxin. a The isogenic set of strains is derived from strain FY1679-28C.
b The congenic set of strains is derived from YALA-B1 and YALA-G4. See material and methods for strain construction. c Pdr5 mediates DON resistance
in the mutant strains collection background. BY4741 and BY4741pdr5Δ were spotted in serial dilution on DON containing YPD medium
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file 1: Table S1 and Additional file 2: Data S1). The 35
deletion strains most sensitive to both DON and TTC
are listed in Table 1 (Additional file 3: Data S2). A previ-
ous study [28] identified 121 strains sensitive to TTC
with 23 overlapping strains reported here (Additional file
4: Data S3). The overlap of identified strains is signifi-
cant (p ~ 5 · 10−10). Many of the mutants found in both
studies have also been isolated in many different screens
[22, 36]. In order to focus on genes involved specifically
in toxin response we marked the notoriously isolated
multidrug sensitive mutants in our analysis (e.g. Table 1;
MDR). These belong to the CCR4-NOT complex (CCR4,
POP2, VMS1), cytoskeleton and endocytosis (RVS161,
RVS167, SAC6, VRP1, SLA1), vacuole (VMA8, VMA11,
VMA13, VMA22), the cell wall integrity pathway (SLT2,
BCK1), URE2 encoding a prion, the sterol desaturase
Table 1 Selected deletion strains sensitive to both TTC and DON
I YORF NAME DON Tcin Term Function MDR
5 YMR078C CTF18 3 3 DNA damage Subunit of a complex with Ctf8p
6 YOR299W BUD7 3 4 Golgi Member of the ChAPs family
7 YEL036C ANP1 3 2 Golgi Subunit of the alpha-1,6 mannosyltransferase complex 2
8 YPR051W MAK3 3 2 Golgi Catalytic subunit N-terminal acetyltransferase
9 YOR147W MDM32 4 4 Mitochondria Mitochondrial inner membrane protein
10 YOR178C GAC1 4 4 PP1 Regulatory subunit for Glc7p type-1 protein Pase (PP1)
11 YCL045C EMC1 2 4 Folding Member of conserved ER membrane complex
12 YIL084C SDS3 3 4 Rpd3 HDAC Component of the Rpd3L histone deacetylase complex
13 YOL004W SIN3 3 4 Rpd3 HDAC Component of both the Rpd3S and Rpd3L HDAC 5
14 YPL139C UME1 3 3 Rpd3 HDAC Component of both the Rpd3S and Rpd3L HDAC
16 YOR043W WHI2 3 3 Stress Required for activation of the general stress response
17 YGL025C PGD1 3 3 Transcription Subunit of the RNA polymerase II mediator complex 1
18 YOR039W CKB2 3 2 Transcription Beta' regulatory subunit of casein kinase 2 (CK2)
19 YEL007W MIT1 3 2 Transcription Transcriptional regulator of pseudohyphal growth
20 YOR298C-A MBF1 2 4 Transcription Transcriptional coactivator 3
21 YJL115W ASF1 2 3 Transcription Nucleosome assembly factor 4
22 YJL176C SWI3 2 3 Transcription Subunit of the SWI/SNF chromatin remodeling complex 1
23 YER064C VHR2 2 3 Transcription Non-essential nuclear protein
24 YLR418C CDC73 2 1 Transcription Component of the Paf1p complex
25 YMR116C ASC1 4 4 Translation G-protein beta subunit 3
26 YDR266C HEL2 4 4 Translation RING finger ubiquitin ligase (E3)
29 YGR271W SLH1 3 4 Translation Putative RNA helicase related to Ski2p
30 YML034W SRC1 3 4 Translation Inner nuclear membrane protein
31 YIR001C SGN1 2 4 Translation Cytoplasmic RNA-binding protein
32 YDR049W VMS1 2 4 Translation Component of the CCR4-NOT transcriptional complex 3
33 YML111W BUL2 4 3 Ubiquitin Component of the Rsp5p E3-ubiquitin ligase complex
34 YEL013W VAC8 4 3 Vacuole Vacuolar membrane protein 5
35 YCL048W SPS22 3 2 Various Protein of unknown function
1 YDR388W RVS167 4 4 Cytoskeleton Actin-associated protein 7
2 YDR129C SAC6 4 4 Cytoskeleton Fimbrin, actin-bundling protein 10
3 YLR337C VRP1 4 4 Cytoskeleton Verprolin, proline-rich actin-associated protein 7
4 YBL007C SLA1 2 4 Cytoskeleton Cytoskeletal protein binding protein 7
15 YLR056W ERG3 3 4 Stress C-5 sterol desaturase 12
27 YAL021C CCR4 4 4 Translation Component of the CCR4-NOT complex 12
28 YNR052C POP2 4 4 Translation Component of the CCR4-NOT complex 10
Sensitivity scores range from 1–4. MDR scores are derived from Parsons et al. 2004
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encoded by ERG3 affecting membrane permeability, the
chromatin remodelling complex subunit Snf2, as well as
a number of other genes (LSM1, BUB1, DBF2, MCH5).
To isolate the resistance promoting processes we func-
tionally categorized the genes (Additional file 2: Data
S1). Assuming that TTC and DON are primarily target-
ing the yeast cytoplasmic ribosome in a very similar if
not identical mode of action, we supposed that a cumula-
tive functional analysis of the obtained genes might be
useful. Gene ontology (GO) annotation of all 248 identi-
fied genes as well as the 35 most sensitive mutants using
the 4780 non-essential genes as background set (http://
go.princeton.edu/cgi-bin/LAGO) yielded a few significant
GO terms. These are including the Rpd3 histone deacety-
lase complex and transcription from RNA polymerase I
and II promoter. Because of the few significant GO terms
we manually categorized the identified genes according to
their cellular function into the major aspects chromatin
metabolism and transcription, amino acid synthesis, cell
wall, mitochondrial functions, ion metabolism, protein
folding and transport, and RNA metabolism (transport,
translation, ribosome biogenesis) (Fig. 2a). Overall the
proportion of DON and TTC sensitive mutants in these
groups is very similar, indicating that both drugs have a
Fig. 2 Analysis of the DON and TTC sensitive mutants. a Categorization of 248 mutants and their representation within the DON and TTC groups.
b Percentage of functional categories in the 35 most sensitive strains. Strains are listed in Additional file 16: Table S2 and supplementary data
files. c Assay plate of the verification plate of the TTC sensitive mutant library strains
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similar effect on yeast physiology. Among the 35 mu-
tants most sensitive to TTC and DON, 60 % of the
respective genes are involved in transcription and
translation (Fig. 2b, Table 1).
Network analysis of genetic interactions
To approach the basic processes encoded in such an as-
sembly of genes with highly diverse functions we ana-
lysed their genetic interactions. Molecular functions are
driven by the collaboration of genes usually represented
in functional groups or pathways. To understand what
these interactions are and how they are governed is a
key question. One way of obtaining this information is
to screen for genetic interactions, which underlie a large
number of biological functions [37]. A network covering
the genome-wide set of genetic interaction in yeast has
been constructed [38], and allows for screening of interac-
tions and clustered groups of interacting genes. Building
upon this genetic interaction information we inferred four
networks representing either a response to TTC, to DON,
to either of these two (union) or both of them (intersec-
tion). To this end we used the corresponding set of genes
as seeds and inferred the corresponding network from the
list of genetic interactions. The resulting networks are
provided as cytoscape file (Additional file 5: Data S4). At
first we inspected the global clustering coefficient, which
indicates the presence of local clusters within the net-
works that might encode for specific functionality. We
found that yeast genetic interaction networks of DON or
TTC responsive genes were more clustered than random
networks (Additional file 6: Figure S1). This was also ob-
served for the network of TTC or DON responsive genes.
The shortest path between a pair of nodes is the minimal
number of edges between them. Shorter path length might
render networks more efficient at processing information
than networks with another topology. This means essen-
tially that a common connecting process exists in such a
network. It has been suggested that small shortest path
lengths might facilitate efficient communication be-
tween transcription factor genes [39]. The three
networks (DON, TTC, DON or TTC) showed a signifi-
cantly shorter average path length then their random
counterparts (Additional file 7: Figure S2). The large
global clustering coefficient and the short path length
present typical properties of small world networks [40].
For the network diameter no such clear pattern was ob-
served. An alternative approach for quantifying the net-
work complexity based on topological properties is to
make use of entropy-based network descriptors [41, 42].
We made use of a parametric graph entropy measure
(Dehmer-entropy) which assigns a probability value to
each node of a graph based on information functionals
distributions [43]. These information functionals capture
the structural information of a graph by considering a
given probability distributions [43]. For DON, TTC, DON
or TTC networks the distance measure of the sphere-
based information functional distributions [43] was found
to be significantly different from random networks (Add-
itional file 8: Figure S3). This observation supports the
idea that the toxin-responsive networks exhibit notable
properties which render them efficient at processing infor-
mation and thus collectively mediate resistance. In con-
trast to the topology of the DON, TTC, and DON or TTC
(union) networks, the network of DON and TTC (inter-
section) responsive genes was not significantly different
from random networks with the same number of seed
genes. Genes representing the intersection of DON and
TTC responsive genes might just represent indirect and
pleiotropic effects of the respective mutants. One of the
main functional clusters present in the intersection net-
work (Fig. 3) was the Rpd3 histone deacetylase complex
(HDAC), involved in transcriptional regulation.
Chromatin remodelling complexes are involved in DON/
TTC resistance
The network analysis points out a HDAC and a few other
highly contributing genes but also shows a tight interaction
over all isolated genes. Thus a common theme is likely em-
bedded in the ensemble of the isolated genes. In the follow-
ing we argue that most mutants impair directly or
indirectly the regulation of cytoplasmic protein synthesis or
the production and maintenance of functional ribosomes.
We concentrate the discussion on groups of mutants that
are highly sensitive and the respective gene products are in-
volved in the same pathway or in the same protein com-
plex. In the group comprising mutants in chromatin
metabolism and transcription, we identified several sub-
units (SDS3, SIN3, UME1, CTI6, TOD6, SAP30, RXT2) of
the RPD3L Histone deacetylase complex and RCO1 of the
RPD3S complex. The histone deacetylase Rpd3 is involved
in repression of RNA Pol II driven rRNA synthesis in sta-
tionary phase [44, 45]. Moreover, loss of the Rpd3 histone
deacetylase, in rpd3 mutants or in mutants lacking SIN3 or
SAP30, results in a delay in rRNA processing but not in an
rRNA transcriptional defect. Genetic evidence also points
to rRNA posttranscriptional modification as a bottleneck in
ribosome biogenesis [46]. This suggests that in Rpd3
mutants, de novo production of ribosomes might be re-
duced, a defect which may become more pronounced in
DON and TTC treated cells due to additional inhibition of
ribosomes. Alternatively, the lack of suppression of intra-
genic spurious transcription by the RCO1 mutant (RPD3S
complex) might generate a burden by overloading RNA
surveillance mechanisms [47]. Furthermore, we identified
three subunits of the SWI/SNF chromatin remodelling
complex (SNF2, SWI3, SNF6). SWI/SNF has been reported
to play a role in transcription by RNA pol I in yeast. A 2.5-
fold reduction in rRNA synthesis rate was reported for
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snf6Δ cells [48]. Moreover, SWI/SNF is required for repres-
sion of RNA polymerase II-dependent transcription in the
ribosomal DNA (rDNA silencing) and telomeric silencing
[49]. Thus reduced or aberrantly regulated rRNA synthesis
in these and other loci (RRP8, REI1, PAF1, PIH1) might be
one underlying reason for the increased DON sensitivity.
Furthermore, we detected DON sensitivity in mutants lack-
ing the histone deacetylases HDA1 or HDA3 (which inter-
act within a complex) and the alternative H2A histone
H2A.Z encoded by HTZ1. Their influence is unclear apart
from the fact that basal transcription of ribosomal genes is
repressed in the corresponding mutants. Another mutant
in a gene with chromatin related function was the HMG
protein Nhp6A which is recruiting the FACT complex
(Spt16-Pob3) and other chromatin remodelling complexes.
NHP6A is required for transcriptional initiation of tRNA
genes and assembly of the RNA polymerase II and III pre-
initiation complexes. Notably, also the CCR4-Not complex
has been reported to be directly involved in rRNA synthesis
[50].
Mitochondria are probably not a direct target of DON
and TTC
Mitochondria have been implicated in the toxic effect of
TTC [27, 28]. Genes connected to mitochondrial
functions identified in this study do not seem to high-
light a specific metabolic activity of mitochondria or
mitochondrial translation. The relatively few mutants re-
lated to mitochondrial function (YMC1, DIC1, MBA1,
UTH1, TOM5) and their low sensitivity does not support
a model with mitochondria as major targets for both
DON and TTC. The most sensitive mutant was lacking
MDM32 a mitochondrial inner membrane protein
required for normal mitochondrial morphology and in-
heritance. MDM32 is upstream of PNO1 an essential
gene required for 18S rRNA processing. Interference of
the knock out cassette with PNO1 expression under
screening conditions cannot be excluded. The possibility
remains that Pdr5-dependent drug efflux clears the cyto-
sol of DON/TTC but not the mitochondrial matrix and
is thus pronouncing effects connected to mitochondria
as observed by other studies [28].
Cell integrity and cytoskeleton are indirectly involved in
DON/TTC resistance
A substantial number of DON/TTC sensitive mutants
were involved in cell integrity and cell wall biosynthesis.
We identified several members of the protein kinase C
(PKC) signalling pathway. These are BCK1 (MAPKKK),



























Fig. 3 The genetic interaction networks of genes responsive to DON and TTC exhibits properties that make them significantly different from random
networks. All three panels show the same network, keeping the same structure and node layout but varying the colouring in order to highlight
different biological properties. In the “functional classification” panel, nodes with the same colour share similar biological properties. In the “DON” and
“TTC” panel different shades of blue and green depict a response to either of the toxins, with stronger colours indicating a more pronounced response
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peripheral plasma membrane, and SLG1 a sensor-
transducer. These mutants are multidrug sensitive [22,
36] and appear to be involved in many diverse processes
such as regulating maintenance of cell wall integrity, cell
cycle, mitophagy and pexophagy and organization of the
actin cytoskeleton. For example, Slt2 plays a role in
vacuole homeostasis and actin dynamics [51]. In
addition to the multifaceted pathology of these mutants,
the cell integrity pathway is also involved in repression
of ribosome and tRNA synthesis in secretion-defective
cells [52]. In addition, we found mutants affecting cell
wall integrity or functionality like 1,3-beta-D-glucan syn-
thase Fks2 or the alpha 1–6 Mannosyltransferases ANP1
and HOC1. Anp1 has been identified as conferring stress
resistance in several instances [53, 54]. Cell wall synthe-
sis is necessarily coupled to growth which in turn is
dependent on biosynthesis. Alternatively, the yeast cell
wall could have a protective role through drug adsorp-
tion properties. Yeast cell walls are sold as feed adjuvant
with trichothecene protective activity [55]. β-glucan, is
used to adsorbe DON [56, 57] and low but significant
adsorption properties have been reported [56, 58]. Mu-
tants impairing the function of the cytoskeleton are multi
drug hypersensitive [36] and were found here to be highly
sensitive to both DON and TTC. Their relative hypersen-
sitivity score (MDR) [36] is listed accordingly (e.g. Table 1).
We identified the interacting Actin-associated proteins
Rvs167 and Rvs161 which have roles in endo- and exocyt-
osis. Other sensitive mutants include Fimbrin (SAC6),
Verprolin (VRP1) a proline-rich actin-associated protein
involved in cytoskeletal organization and cytokinesis, and
SLA1 required for assembly of the cortical actin cytoskel-
eton. Pbs2, the MAPKK of the high osmolarity glycerol
(HOG) pathway has also a function in restructuration of
the cytoskeleton [59]. A possible reason why such mutants
appear in many screens is the observation that rRNA
levels are repressed in various mutants with defects in
transport and exocytosis [60]. The unfolded protein path-
way is apparently not prominently involved in TTC resist-
ance. The ire1 mutant was weakly sensitive to TTC and
not to DON. Protein phosphatase 1 (PP1) is an enzyme
clearly important for resistance against DON since we
identified three genes belonging to PP1 interactors
(REG1, GIP4, GAC1). The catalytic subunit of PP1
(GLC7) is an essential gene and therefore not in-
cluded in the collection and functions to promote cell
integrity, mitosis, bud morphology and polarization of
the actin cytoskeleton. Thus PP1 might indirectly
have a profound influence on ribosome synthesis.
Many mutants impair ribosome and ribosome quality
control constituents
Genes functionally related to translation comprised sev-
eral categories: ribosomal subunits (RPL39, RPL21A,
RPS27B, RPS21A, RPS23B,), ribosome assembly (BUD20,
CMS1, RPP1A, REI1, RRP8 rRNA methyltransferase),
the Cop9 signalosome components (YJR084W, PCI8),
initiation (SGN1, GCN3, GIS2, BUD27) and RNA turn-
over. Furthermore, we identified genes involved in RNA
degradation such as LSM1, the Ski complex (SKI2,
SKI8), and SLH1 (RNA helicase related to Ski2), and
mRNA decapping (EDC3, PAT1), and splicing (BRR1,
LEA2). Interstingly, bud morphology defects can par-
tially be attributed to impaired ribosome function. A
screen for abnormal bud morphology [61] detected 111
mutants including 15 genes (significance p = 0.0006)
here identified as DON and/or TTC sensitive. These in-
clude functions in translation (RPS27B, RPL39, POP2,
CCR4, BUD27, BUD20), cell wall (SLG1, PER1, FKS1,
CCW12) and cytoskeleton (SLA1, RVS167, RVS161).
Furthermore, DON and/or TTC sensitive mutants with
defects in tRNA synthesis and processing involved uri-
dine thiolation of cytoplasmic tRNAs (NCS6, URM1,
IKI3), a non-canonical poly(A) polymerase which cataly-
ses polyadenylation of hypo modified tRNAs, snoRNA
and rRNA precursors (TRF5), and a Zinc-finger protein
Stp3 possibly involved in pre-tRNA splicing. An interest-
ing connection to possible oxidative stress caused by
trichothecenes is the thioredoxin peroxidase Tsa1 which
acts as ribosome-associated antioxidant [62]. However,
other genes with dedicated antioxidant functions were
not found. Biotransformation of trichothecenes occurs
partially through glutathione addition [17]. A prominent
influence on DON/TTC detoxification by formation of
glutathione conjugates in yeast is not supported by our
data. An exception is the prion encoded by URE2, which
can mutate to a glutathione transferase but it is involved
in growth related processes as well and thus the effect of
the mutant might be rather indirect.
The mutant strain with the most striking sensitivity
against DON was lacking HEL2/YDR266C. Hel2 is an E3
ligase and has been linked genetically with the E2 Ubc4.
Hel2 has initially been implicated in histone turnover
[63] and connected to translation and ribosome quality
control (RQC) [64, 65]. Genetic data identified HEL2 as
a high-copy-number suppressor of an allele of Mpe1, a
conserved subunit of the cleavage and polyadenylation
factor (CPF) [66]. Hel2 and Asc1 are factors for polypep-
tide quality control upstream of RQC [67, 68]. This is in
line with the action of DON and TTC on early stages of
translation. The RQC complex (Rqc1-Rkr1-Tae2-Cdc48-
Npl4-Ufd1) is a ribosome-bound complex required for
the degradation of polypeptides arising from stalled
translation [67, 69]. We tested mutants lacking RQC1
and RKR1 and found no indication for increased DON
or TTC sensitivity. Paromomycin is an aminoglycoside
inducing the ribosome to bypass premature termination
codons and to relax the stringency of decoding [70]. To
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investigate if DON/TCC toxicity is suppressed in the
presence of paromomycin we determined the maximal
growth rate in presence or absence of DON (12 mg/l)
and a range of paromomycin concentrations (Additional
file 9: Figure S4). We find a more than additive growth
inhibition of the drug combination on pdr5Δ cells.
Interestingly, we noted a higher resistance of the hel2Δ
strain to higher doses (0.25 to 1 g/l) of paromomycin
(Additional file 9: Figure S4A). Thus DON-induced
stalling of ribosomes is not efficiently released by
paromomycin-induced relaxation.
We confirmed the phenotype of the HEL2 deletion mu-
tant by re-testing the original deletion strain of the or-
dered strain collection (Fig. 4a) and by deleting the HEL2
gene in a different strain background. For confirmation,
we used a strain not related to the library strain and be-
cause of the low toxicity of DON lacking ABC trans-
porters (Pdr5, Pdr10, Pdr15) as well as the yeast acetyl
transferase Ayt1 [18]. The serial dilution tests showed a
clear sensitivity of the respective HEL2 deletion mutants
to DON and TTC. Since resolving of stalled ribosomes is
an activity occurring also in unperturbed cells we expected
that the HEL2 gene overexpressed under the control of
the ADH1 promoter might improve the ribosome clearing
capacity. Indeed, overexpression of Hel2 conferred a slight
growth advantage in presence of DON in the growth test
(Fig. 4b). Growth assays using different DON concentra-
tions (Fig. 4c) showed a marked dose-dependent decrease
of growth of the mutant but also a gain of resistance by
overexpression of HEL2. This gain is detectable in the wild
type and the complemented hel2Δ strain (Fig. 4c). Thus
Hel2 becomes limiting in DON treated cells. Also the
maximal growth rate was found to be reduced in the
DON treated strain relative to the wild type (Fig. 4d).
Asc1, a homolog of human RACK1 (human receptor
for activated C-kinase 1) and Hel2 have been implicated
in translation through polybasic peptide sequences, and
may act after the ribosome has translated some distance
[67, 71]. Asc1, a core component of the small (40S) ribo-
somal subunit which prevents frameshifting of stalled
ribosomes at repeats of CGA codons is related in its ef-
fective function to Hel2 [71, 72]. Translation of CGA
codon repeats is inefficient, resulting in dose-dependent
stalling of ribosomes [73]. In this respect it is interesting
to note the TTC sensitivity of some mutants defective in
arginine biosynthesis (ARG4, ARG5,6) as well as mem-
brane transporters for cationic amino acids (RTC2,
YPQ1, VBA5). These mutants could decrease the argin-
ine pools and thus lower the availability of the rare
tRNA-Arg(UCG). Also several methionine biosynthesis
genes were identified (HOM6, MET12,13,14,22,31). The
ASC1 gene contains an intron harbouring a snoRNA
transcript unit (snoRNA U24). To distinguish between
Asc1 and snoRNA dependent phenotypes we tested a
mutant expressing the snoRNA U24 but not Asc1p due
to a truncation of the first exon [74, 75] and found no
effect from the U24 RNA (Fig. 4e). Thus the strong
DON and TTC sensitivity of the mutant is due to the
absence of Asc1. Asc1 is also required for general cell
wall integrity and mutants are hypersensitive to iron
starvation [74]. In that respect it is interesting to note
that we detected genes involved in Iron metabolism
(FRA1, FET4, NFU1, MTM1), as well as, a high-affinity
copper transporter of the plasma membrane (CTR1) and
ARR1 a transcriptional activator involved in resistance to
arsenic compounds. The Rsp5 E3-ubiquitin ligase is in-
volved in endocytosis, membrane protein trafficking and
protein quality control and thus indirectly in many cellu-
lar processes but notably also in amino acid permease
sorting [76, 77]. RSP5 is an essential gene and is there-
fore not present in the mutant collection but genes of
two interacting proteins were identified. BUL2 coding
for a component of the Rsp5p E3-ubiquitin ligase com-
plex and RUP1 coding for a protein that regulates
ubiquitination of Rsp5p. Taken together, we suspect that
many of the isolated mutants ultimately influence cyto-
plasmic translation and thus cause synthetic phenotypes
in the presence of DON and TTC.
Transcription profiling reveals demand for ribosomes and
histones in DON treated cells
Gene expression pattern analysis is a powerful method
to detect transcriptional responses and to deduce active
signalling pathways in a given situation. Here we investi-
gated whether specific intracellular responses are elicited
by DON. We used 12 mg/l and 24 mg/l of DON which
caused a slight growth delay and treated exponentially
growing cells lacking Pdr5. DON was added when the
cultures reached OD600 of 0.5 and cells were harvested
when the cultures reached an OD600 of 1 or 1.5 and
compared to untreated control cultures at the same op-
tical density. To define the difference between short
term and long term responses, we incubated cells with
24 mg/l DON overnight and re-grew them in fresh
medium containing 24 mg/l DON to early exponential
phase (OD600 of 0.1 to 1). All measurements were done
in triplicate. Expression data were filtered and 382 genes
were selected according to fold change values of above
0.5 or below−0.5 (log2) in at least one condition and
analysed for GO term enrichment. We found enrich-
ment of genes involved in mitochondrial respiratory
chain function and amino acid biosynthesis, however,
the distribution is almost even between the induced and
repressed genes (Fig. 5a). Notably, the selected genes do
not represent a specific cellular response. The gene lists
and GO analysis are provided as supplementary data
(Additional file 10: Data S5, Additional file 11: Data S6).
We further analysed the absolute changes of signal





Fig. 4 Deletion of HEL2 confers hypersensitivity to TTC and DON. a Spot assay of the confirmed hel2Δ deletion strain in the wild type BY4741
strain background. b Spot assay of the hel2Δ deletion in a drug hypersensitive strain background (YZGN1). c Growth assay of the YZGN1 and
YZGN1hel2Δ strains in presence of an HEL2 overexpressing plasmid and the vector control. d Determination of growth rate of DON treated
YZGN1 and YZGN1hel2Δ. e The absence of Asc1 expression causes TTC hypersensitivity but not the intron encoded snRNA
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abundance to define those transcripts which undergo
the largest quantitative changes. The obtained expres-
sion level differences were normalized and arranged by
hierarchical clustering (Fig. 5b). Significantly enriched
GO terms connected to expression level differences re-
vealed reduction of genes of glycolysis and amino acid
biosynthesis and increase of genes involved in cyto-
plasmic translation. Interestingly, in this selection the
levels of most ribosomal protein genes and all histone
genes increased. Furthermore, expression level differ-
ences increase for most ribosomal protein genes
(Fig. 5c, Additional file 12: Data S7). This possibly points
to a situation caused by DON where translation is lacking
behind the available carbon and energy sources. Reduced
biomass production demand due to restricted growth
leads to reduced glycolytic flux and a switch to respiration
as energy source.
Many deletion strains sensitive to DON and TTC are
sensitive to many other drugs as well [36]. Notorious
multidrug sensitive strains have defects in functions of
vacuole, cytoskeleton and cell wall. These mutants lead
to a reduction of rRNA synthesis since growth and ribo-
some synthesis is tightly coupled [60]. One common re-
sponse to environmental perturbations is the delay of
Fig. 5 Microarray analysis of DON treated cells reveals both induced and repressed mitochondrial related genes and induced amino acid biosynthesis
genes. Genes with the largest increase of transcript level (differences) are connected to cytoplasmic translation and ribosome synthesis whereas
glycolysis and amino acid biosynthesis genes are repressed. Clustering of normalized and filtered expression values including enriched GO terms is
indicated. a fold change values and b expression level differences. c Expression differences and fold change of 120 ribosomal protein genes
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the cell cycle progression. For example, various environ-
mental stress types trigger depolarization of the actin
cytoskeleton and cause a delay of the G2 phase of the
cell cycle. On the other hand, mutations or drugs that
specifically impair actin organization also trigger a G2
delay [78]. Many mutants with defects in various intra-
cellular processes lead to a delay of G2. Both delay of
the cell cycle and environmental stress lead to a charac-
teristic gene expression pattern designated "slow growth
signature" [79]. This transcript pattern is characterized
by reduced expression of genes involved in protein syn-
thesis such as ribosomal protein genes and glycolysis
and the increase of transcripts of genes connected to re-
spiratory growth. We collected the available microarray
data for our DON and TTC sensitive mutants [79] and
aligned the normalized DON treatment expression data
(Figs. 6a and Additional file 13: Figure S5). The gene lists
and values generating the heat maps are provided as
supplementary data (Additional file 14: Data S8, Add-
itional file 15: Data S9). We note a high proportion of
strains exhibiting the slow growth signature (Pattern A)
amongst our sensitive mutants suggesting that many
mutant strains are suppressing ribosome production
without treatment. Exposure to DON possibly leads to
further reduced availability of translation capacity in
these mutants due to degradation and stalling of trans-
lating ribosomes. CTI6, PDE2, YKR023W, VAC8, URM1,
IRE1, APQ12, NTH2, URE2, VHR2, and RTG1 have the
inverse transcript pattern (Pattern B). The comparison
of the transcript profiles of DON-treated cells to the
compendium pattern shows a slow growth signature for
the early time points and a switch to the inverse pattern
at later time points and during chronic exposure
(Fig. 6b). Taken together this implies a reduced ribosome
synthesis rate in many mutants which might be exacer-
bated by DON induced stalling during translation.
Conclusion
Yeast loss of function mutants isolated here as DON or
TTC sensitive collectively point to cytoplasmic translation,
ribosomal efficiency and rRNA synthesis as rate limiting
for fitness in the presence of these toxins. Transcriptome
analysis of DON treated cells shows an increase of the
transcript level of many genes encoding ribosomal protein
genes and histones. This perhaps suggests that cells are
preparing to enhance biosynthesis. The connector be-
tween these observations is the fact that regulation of
ribosome synthesis is closely tied to regulation of cell
growth rate. Synthesis of ribosomes requires a substantial
proportion of the cellular biosynthetic activity. For ex-
ample, synthesis of rRNA by RNA polymerase I is the
major transcriptional activity of the cell, accounting for
60 % of total transcription in rapidly growing yeast cells to
allow for the production of ribosomes in rapidly growing
cells [80]. Yeast cells are optimizing their growth corre-
sponding to available nutrients [80]. DON and TTC treat-
ment is impairing the 80S ribosome and thus reducing the
biosynthetic capacity of yeast cells. In this respect, our ob-
servation of increased levels of transcripts coding for ribo-
somal genes and histones makes sense from a yeast
perspective. Relatively lower translation fidelity in pres-
ence of DON or TTC would call for increased synthesis of
ribosomes to provide the appropriate biosynthetic capacity
to utilize the available nutrients. Our result that overex-
pression of Hel2 increased resistance to DON is suggest-
ing that ribosome fidelity is a primary bottle neck of
fitness. Asc1 and Hel2 are both involved in ribosome qual-
ity control and facilitate co-translational protein ubiquiti-
nation, translation termination and possibly RNA cleavage
[68]. Mutants in genes functioning at later stages of ribo-
some quality control such as RKR1 and RQC1 deletion
mutants were not sensitive to TTC and DON suggesting
that Asc1/Hel2 is sufficient to resolve the DON/TTC
Fig. 6 Comparative transcription pattern analysis. a The Microarray expression pattern of DON and TTC sensitive mutants highlights a slow
growth expression pattern in many strains. b DON treated cells have an initial dose dependent slow growth expression pattern (Type A: blue
bars) which is inverted (Type B: orange bars) at later time points. Expression values of the genes of the DON treatment are sorted in parallel to
the heat map of the microarray compendium depicted below. Expression values were obtained from http://deleteome.holstegelab.nl/
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induced translation problem. Network analysis of the iso-
lated mutants indicates a tight network, containing the
Rpd3 histone deacetylase complex, centred on core intra-
cellular processes. The overall genetic interaction net-
works of DON or TTC sensitive strains allowed the
conclusion that a common mechanism is involved. We
believe this is a cytoplasmic mechanism. Earlier work sug-
gested a primarily mitochondrial component of Tricho-
thecene toxicity. Microarray analysis of yeast exposed to
T2 toxin showed induced oxidative stress and indications
point to an effect on mitochondria [81, 82]. Similarly, a
critical role of mitochondria for TTC toxicity was shown
[27, 28]. Our data do not support an effect of DON and
TTC on mitochondria. This may be partly rooted in the
absence of Pdr5. The efflux pump might reduce the cyto-
plasmic pool of toxin but mitochondria might trap a sub-
stantial amount. Thus, in the pdr5 mutant the
cytoplasmic concentration might be higher and lead pref-
erably to inhibition of cytoplasmic ribosomes. Further dif-
ferences to published microarrays are also most probably
treatment related [34].
The perturbation of growth promoting activities leads
in many cases to reduced synthesis of components of
the translation machinery [79]. Many mutants isolated
here evoke a growth delay [79] also caused by adverse
external parameters and many types of internal malfunc-
tions. The pattern characterizes a reduction of ribosome
synthesis and glycolysis. It is tempting to speculate that
the tendency of many mutants to reduce cytoplasmic
translation is exacerbated by additional inhibition by the
trichothecene toxins. The response mechanisms of
higher eukaryotes cells are of course much more compli-
cated [83]. Our results might provide a useful back-
ground of functional genomics to contrast against and
to highlight specific responses of plant and animal cells.
A recent gene expression study of DON treated wheat
demonstrated induction of amino acid biosynthesis
genes and the expression of an E3 ligase in response to
Fusarium [84]. Transcriptome analysis of TTC-induced
expression in barley identified specific responses includ-
ing ubiquitination related protein genes [85]. Notably,
we identify the E3 ligase Hel2 involved in early transla-
tional quality control as possible functional analogue of
the wheat Fhb1 QTL. Moreover, Hel2 was also picked in
the previous screen for TTC sensitive strains [28]. Thus
our study pinpoints cytoplasmic translation as the pri-
mary target of DON and TTC and we therefore suggest
mechanisms enhancing translation or recovery of stalled
ribosomes as main source of trichothecene resistance.
Methods
Yeast strains used in this study are listed in Additional file
16: Table S2. The strain FY1679-28C (MATa ura3-52
leu2Δ1 his3Δ200 trp1Δ63) and the derived double mutant
pdr1Δ pdr3Δ have been described [86]. YZGA280 was
generated by transformation of FY1679-28C with the
pdr5Δ::hisG-URA3-hisG disruption plasmid pYM31 [87]
followed by counter selection with 5-fluoro-orotic acid
(pdr5Δ::hisG). YZGA260 was generated by transformation
of the pdr1Δ pdr3Δ mutant with plasmid pYAK7 [18] lead-
ing to ADH1 promoter mediated overexpression of an N-
terminally c-Myc-tagged Pdr5 protein. The pdr5::hisG dis-
ruption was also introduced into the previously described
[87] near isogenic strains YALA-B1 and YALA-G4 (contain-
ing PDR1-3) to generate strains YZGA276 (pdr5Δ) and
YZGA278(PDR1-3, pdr5Δ). YZGN1 (pdr5Δ::loxP-his5+-loxP,
pdr10Δ::hisG, pdr15Δ::loxP-NatMX-loxP, ayt1Δ::URA3) was
constructed by replacing the TRP1 gene at the PDR5 locus
with pUG27 derived loxP-his5+-loxP cassette [88] in strain
YZGA515 (pdr5Δ::TRP1, pdr10Δ::hisG, pdr15Δ::loxP-
KanMX-loxP, ayt1Δ::URA3) [18] and the derivative YZGN1
hel2Δ::kanMX. The synthetic genetic array analysis was per-
formed according to the published protocol [35]. The query
strain Y7092 pdr5Δ:: NatMX was constructed according to
[35]. To introduce the pdr5Δ mutant allele, the ordered
S.cerevisiae EUROSCARF mutant library was mated with
the query strain Y7092 pdr5Δ:: NatMX. Diploid cells carry-
ing resistance cassettes and presumably the corresponding
deletion mutations were selected on kanamycin (200 mg/l)
and nourseothricin (100 mg/l). The selected diploids were
pinned on sporulation media supplemented with 50 mg/l of
kanamycin. After 10 days at room temperature haploid seg-
regants were selected for growth on medium containing
kanamycin (200 mg/l) and lacking histidine and, followed by
transfer of the resulting colonies to medium supplemented
with kanamycin, nourseothricin (100 mg/l) and canavanine
(50 mg/l) and lacking histidine for 3 to 5 days at 30 °C. The
resulting haploid screening collection was stored at−80 °C
and selected after thawing. Solid pinning was done with a
ROTOR HDA (Singer Inc, GB). For screening the density
was increased to 384 strains per plate and pinning was done
as dilution pinning with 4 successive touches of the medium
surface. Plates contained 70 to 130 mg/l DON and 3 mg/l
TTC. Strains of interest were thawed, grown on YPD plates
at 30 °C and then transferred to SC-His media containing
kanamycin (200 mg/l) for 3 days at 30 °C. The selection of
was performed on SC-His media supplemented with kana-
mycin (200 mg/l), nourseothricin and canavanine (50 mg/l)
for 3 days. Growth rates were determined in triplicate in 96
well format in YPD. OD600 values of growth curves mea-
sured in 30 min intervals were fitted with grofit(R) to obtain
μ/h values.
DON (purity >98 %) was produced and purified accord-
ing to Altpeter and Posselt [89]. TTC was isolated form
potato dextrose broth cultures of the Trichothecium
roseum strain MA 3581 (obtained from the Austrian
Center of Biological Resources) by preparative HPLC as
described [90].
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Network analysis: To create the DON and TTC respon-
sive networks we used the genes that were found in our
screen to be reacting to treatment with either DON or
TTC as seeds. In order to filter out unspecific, general
toxicity-related genes we removed genes that have been
found as responsive to MDR at a score higher than 3 [36].
Interactions from the intermediate stringency level yeast
genetic interaction network [38] were selected if both
interaction partners were within the set of remaining
seeds. The corresponding networks were then visualized
using Cytoscape [91] and topological properties were cal-
culated using the igraph, RBGL, and QuACN packages in
R [92–95]. The information-theoretic distance measure
was calculated by the infoTheoreticGCM method (param-
eter: coeff=”exp”) as provided by the QuACN package
[94]. For analyzing the topological properties the largest
connected component of the respective selected networks
was selected. To compare the observed topological prop-
erties against random characteristics we inferred B = 1000
networks using the same number of seed genes, but re-
placing the actual seeds by randomly sampled genes from
the genetic interaction network universe for each run.
Microarray analysis: RNA quality was checked on
RNA 6000 Nano chips using a Bioanalyzer 2100 (Agi-
lent Technologies, Palo Alto, CA, USA). Agilent’s Low
Input Quick Amp Labeling Kit, one-color was used to
generate fluorescent cRNA. The amplified cyanine 3-
labeled cRNA samples were then purified using SV
Total RNA Isolation System (Promega) and hybridized
to Agilent Yeast (V2) Gene Expression Microarrays
8x15K. Microarray slides were washed and scanned with
an Agilent Scanner, according to the standard protocol
of the manufacturer. Information from probe features
was extracted from microarray scan images using the
Agilent Feature Extraction software v10.7.3. Further
analyses were performed using Bioconductor [96], an
open source software for the analysis of genomic data
rooted in the statistical computing environment R. The
raw intensities were imported into Bioconductor and
further processed with the limma [97] package. Quality
Controls were performed using the arrayQualityMetrics
package [98]. To reduce the effects of outliers, the out-
lier array #4 was removed. Data was background cor-
rected using the normexp method of limma, with an
offset of 32 to stabilize low intensity variances.
Normalization between arrays was performed using the
quantile method, duplicate probes were averaged and a
linear model was fitted. P-values were adjusted for mul-
tiple testing using the Benjamini & Hochberg method.
Differences were calculated from raw intensity data
followed by log transformation and normalization with
cluster3 [99]. Microarray data have been deposited at
GEO with the accession number GSE75462. Data from
large scale expression analysis were obtained from
http://deleteome.holstegelab.nl/ [79]. Visualization of
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